Astellas Pharma (Astellas Pharma) Accounts Payable & Accrued Expense : $1,287 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Astellas Pharma Accounts Payable & Accrued Expense?

Astellas Pharma's quarterly accounts payable & accrued expense increased from Jun. 2023 ($1,094 Mil) to Sep. 2023 ($1,208 Mil) and increased from Sep. 2023 ($1,208 Mil) to Dec. 2023 ($1,287 Mil).

Astellas Pharma's annual accounts payable & accrued expense increased from Mar. 2021 ($1,225 Mil) to Mar. 2022 ($1,376 Mil) but then declined from Mar. 2022 ($1,376 Mil) to Mar. 2023 ($1,088 Mil).

Astellas Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Astellas Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Accounts Payable & Accrued Expense Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,825.26

1,634.32

1,225.14

1,375.70

1,087.60

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,131.71	1,087.60	1,094.45	1,207.85	1,286.61

Astellas Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ALPMY:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.